chemosensitivity

Open Access
Anlotinib Inhibits Ovarian Cancer and Enhances Cisplatinum Sensitivity via Suppressing NOTCH2 Expression and Stemness
XIAOSHENG XU, QUN WANG, LIFEI SHEN, YUHONG SHEN, HUA LIU, YAN LIU, ZHIJIAN YANG, ROBERT M. HOFFMAN and WEIWEI FENG

Anticancer Research April 2024, 44 (4) 1399-1407; DOI: https://doi.org/10.21873/anticanres.16936
You have access
RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression
HIROAKI NAGAMINE, MASAKAZU YASHIRO, NAOKI YOSHIMOTO, MOTOHIRO IZUMI, AKIRA SUGIMOTO, KENJI NAKAHAMA, KOICHI OGAWA, YOSHIYA MATSUMOTO, KENJI SAWA, YOKO TANI, HIROYASU KANEDA, SHIGEKI MITSUOKA, KAZUHIRO YAMADA, TETSUYA WATANABE, KAZUHISA AASAI, KAZUHIRO FUKUMURA, AKILA MAYEDA and TOMOYA KAWAGUCHI

Anticancer Research October 2023, 43 (10) 4663-4672; DOI: https://doi.org/10.21873/anticanres.16662
You have access
FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lines
SEBASTIAN K.S. BEGG, DAVID J. BIRNBAUM, JEFFREY W. CLARK, MARI MINO-KENUDSON, ULRICH F. WELLNER, OLIVER SCHILLING, KEITH D. LILLEMOE, ANDREW L. WARSHAW, CARLOS FERNÁNDEZ-DEL CASTILLO and ANDREW S. LISS

Anticancer Research July 2020, 40 (7) 3659-3667; DOI: https://doi.org/10.21873/anticanres.14355
You have access
Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells
GUL NABI KHAN, EUN JIN KIM, TAE SEOP SHIN and SANG HO LEE

Anticancer Research May 2017, 37 (5) 2355-2364;
You have access
Clinical Significance of 5-Fluorouracil Chemosensitivity Testing in Patients with Colorectal Cancer
WOONG BAE JI, JUN WON UM, JE SEOCK RYU, KWANG DAE HONG, JUNG SIK KIM, BYUNG WOOK MIN, SUNG YEOP JOUNG, JU HAN LEE and YOUNG SIK KIM

Anticancer Research May 2017, 37 (5) 2679-2682;
You have access
CD24 Modulates Chemosensitivity of MCF-7 Breast Cancer Cells
HIDEYA ONISHI, KUMI SUYAMA, AKIO YAMASAKI, YASUHIRO OYAMA, AKIKO FUJIMURA, MAKOTO KAWAMOTO and AKIRA IMAIZUMI

Anticancer Research February 2017, 37 (2) 561-565;
You have access
Molecular Factors Associated with Pemetrexed Sensitivity According to Histological Type in Non-small Cell Lung Cancer
TSUKIHISA YOSHIDA, TATSURO OKAMOTO, TOKUJIRO YANO, KAZUKI TAKADA, MIKIHIRO KOHNO, KENICHI SUDA, MITSUHIRO TAKENOYAMA, YOSHINAO ODA and YOSHIHIKO MAEHARA

Anticancer Research December 2016, 36 (12) 6319-6326;
You have access
Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate
KAREN BRÄUTIGAM, KATHARINA MITZLAFF, LISA UEBEL, FRANK KÖSTER, STEPHAN POLACK, MASCHA PERVAN, GUNNAR STEINERT, ACHIM RODY and CORNELIA LIEDTKE

Anticancer Research June 2016, 36 (6) 2759-2766;
You have access
Comparative Chemosensitivity of VX2 and HCC Cell Lines to Drugs Used in TACE
FLORENTINA PASCALE, LAURENT BEDOUET, MINTHAM BAYLATRY, JULIEN NAMUR and ALEXANDRE LAURENT

Anticancer Research December 2015, 35 (12) 6497-6503;
You have access
Associations Between Driver Gene Mutations and Cytotoxic Chemosensitivity in Patients with Non-small Cell Lung Cancer
YOSUKE MORODOMI, TATSURO OKAMOTO, MIKIHIRO KOHNO, MASAKAZU KATSURA, KAZUKI TAKADA, YUZO SUZUKI, TAKATOSHI FUJISHITA, HIROKAZU KITAHARA, SHINICHIRO SHIMAMATSU, TSUKIHISA YOSHIDA, TETSUZO TAGAWA, SHINJI OKANO and YOSHIHIKO MAEHARA

Anticancer Research March 2015, 35 (3) 1791-1796;

Main menu

User menu

Search

chemosensitivity

Pages